TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer.
about
Transcriptional profiling in rat hair follicles following simulated Blast insult: a new diagnostic tool for traumatic brain injuryColon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid.Expression and distribution of transient receptor potential (TRP) channels in bladder epithelium.Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activationWhat do we know about the transient receptor potential vanilloid 2 (TRPV2) ion channel?The TREK2 Channel Is Involved in the Proliferation of 253J Cell, a Human Bladder Carcinoma CellLoss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor ProgressionIon channnels and transporters in cancer. 5. Ion channels in control of cancer and cell apoptosis.From urgency to frequency: facts and controversies of TRPs in the lower urinary tract.Role of ion transport in control of apoptotic cell death.Ion channels in cancer: future perspectives and clinical potential.Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture.Overexpression of transient receptor potential vanilloid 2 is associated with poor prognosis in patients with esophageal squamous cell carcinoma.Biophysical characterization of bladder cancer cells with different metastatic potential.Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpesvirus-infected endothelium.Effect of TRPV2 cation channels on the proliferation, migration and invasion of 5637 bladder cancer cells.CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway.Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor.The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2.TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer
P2860
Q27315925-B1086047-7249-4428-AA05-FFC54AAE94D6Q34441093-6D1AC68A-3BC1-42B2-92F4-AAD0F1556028Q34501891-6AFFE35D-A180-4262-B094-BB308394BB1DQ35966006-28C2A7B0-E558-47F9-9A84-988A8DE1CC7AQ37198480-04CCB969-2E2F-495B-A91B-26EC85CF578BQ37417632-35C795D6-0042-4B97-9BD8-D43EC9560C19Q37693612-E2B222F9-2816-41D3-88D7-36F2083FBAD2Q37937313-09F1E8C5-BB81-45CD-90C2-3A6D1CE24FD6Q37942411-849F4157-FBD4-4AFA-80D0-68EFCAE96476Q38110755-5FD5C321-4CF2-4898-AA5F-E4E9569E2CC6Q38184990-2B5F8792-220C-41C1-B2BB-ED29234C4F00Q38732473-A06B668A-879B-49F2-8908-9DCA70E5E62FQ38989973-0AE41293-FC9A-4A3A-84C6-5F3BC09B59FFQ39136134-A0CD74D7-9F89-4A2C-BE68-53C61305ADEDQ42425087-D128BBCC-8C55-4BA1-84DF-33F18B7B4D06Q42917821-BCBA3AB1-D07F-4A77-B53C-3800AA2404B9Q47103599-50549347-05BB-4BBF-B237-1EEB6391CB73Q50661138-B7E7E628-250E-47E3-BC4D-1D28E7CA579DQ53080643-67CB542D-6F20-4EB1-B872-E66ADE622177Q57498794-B5E34AD6-1942-42B3-9825-4E7E6F57616D
P2860
TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
TRPV2 activation induces apopt ...... tic target for bladder cancer.
@en
TRPV2 activation induces apopt ...... tic target for bladder cancer.
@nl
type
label
TRPV2 activation induces apopt ...... tic target for bladder cancer.
@en
TRPV2 activation induces apopt ...... tic target for bladder cancer.
@nl
prefLabel
TRPV2 activation induces apopt ...... tic target for bladder cancer.
@en
TRPV2 activation induces apopt ...... tic target for bladder cancer.
@nl
P2093
P1433
P1476
TRPV2 activation induces apopt ...... tic target for bladder cancer.
@en
P2093
Kenjiro Kohri
Masaki Saito
Shinya Ugawa
Shoichi Shimada
Takahiro Yamada
Takashi Ueda
Yasuhiro Shibata
Yosuke Ikegami
Yusuke Ishida
P304
P356
10.1016/J.UROLOGY.2010.03.029
P407
P577
2010-05-23T00:00:00Z